Conference entitled Safety Evaluation of Immunomodulatory Biopharmaceuticals: Can We Improve the Predictive Value of Preclinical Studies?, Bethesda, MD, USA, 23-24 September 1999: Introduction

Human and Experimental Toxicology

Volumn 19, Issue 4, 2000, Pages 205-207

  Black, L E ^a   Green, J D ^b   Rener, J ^c   Dayan, A ^c   Cavagnaro, J A ^d   Spindler, P ^e   Bussiere, J L ^f   Bouchard, P ^g   Inoue, T ^h   Thomas, P T ^c   Essayan, D M ^a   Gillett, N A ⁱ   Hart, T K ^d   Hastings, K ^j   House, R V ^c   Latta, D ^k   Liminga, U ^l   Treacy, G ^m   Wierda, D ⁿ  

^a Center for Biologics Evaluation and Research   (United States)

^b BIOGEN   (United States)

^c Covance Laboratories ^*  (United States)

^d Access BIO ^*  (India)

^e NOVO NORDISK A S   (Denmark)

^f Immunex   (United States)

^g Genetics Institute   (United States)

^h NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

ⁱ CHARLES RIVER LABORATORIES   (United States)

^j Center for Drug Education and Research   (India)

^k Wyeth Ayerst Research   (Canada)

^l MEDICAL PRODUCTS AGENCY   (Sweden)

^m CENTOCOR INC   (United States)

ⁿ ELI LILLY AND COMPANY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGICAL ADJUVANT; IMMUNOMODULATING AGENT;

ARTICLE; DRUG SCREENING; PHARMACEUTICS; CARCINOGENICITY; DRUG DEVELOPMENT; DRUG SAFETY; EDITORIAL; HUMAN; IMMUNOCOMPETENCE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RODENT; TERATOGENICITY; TOXICOLOGY;

ADJUVANTS, IMMUNOLOGIC; BIOPHARMACEUTICS; DRUG EVALUATION, PRECLINICAL;

PRIMATES; RODENTIA;

EID: 0034167943     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/096032700678815855     Document Type: Editorial

References (0)